Avanos Medical (AVNS) to Release Quarterly Earnings on Wednesday

Avanos Medical (NYSE:AVNS) is anticipated to announce its earnings results before the market opens on Wednesday, February 26th. Analysts expect the company to announce earnings of $0.40 per share and revenue of $177.23 million for the quarter. Investors that are interested in participating in the company’s conference call can do so using this link.

Avanos Medical Trading Up 0.0 %

NYSE:AVNS opened at $15.49 on Monday. The company has a debt-to-equity ratio of 0.12, a current ratio of 2.22 and a quick ratio of 1.46. Avanos Medical has a fifty-two week low of $14.98 and a fifty-two week high of $25.36. The stock’s 50-day moving average is $16.22 and its two-hundred day moving average is $19.83. The stock has a market cap of $711.78 million, a PE ratio of 45.55 and a beta of 0.98.

Analyst Ratings Changes

Separately, StockNews.com cut Avanos Medical from a “strong-buy” rating to a “buy” rating in a research note on Sunday, November 3rd.

Avanos Medical Company Profile

Avanos Medical, Inc, a medical technology company, offers medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers a portfolio of chronic care products that include digestive health products, such as Mic-Key enteral feeding tubes, Corpak patient feeding solutions, and NeoMed neonatal and pediatric feeding solutions.